Information for Patients and Caregivers

This site contains information on skin, mouth and hair changes (known as adverse reactions) that can sometimes occur with a particular type of cancer drug, known as multikinase inhibitors. This section is for patients receiving the following cancer treatments only: Stivarga® (regorafenib), Nexavar® (sorafenib), Caprelsa® (vandetanib), Sutent® (sunitinib), Glivec® (imatinib). Here, we aim to bring you important information on how you can work with your doctor/nurse to manage skin, mouth and hair adverse reactions to your cancer treatment.